Physician profile
Janice Wang
NPI 1942468509
$4,089.54
in general payments reported to CMS, 2019-2025
13 companies · $3,460 in 2025
The $3,460 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2022: $39.82 · 2023: $455 · 2024: $15.24 · 2025: $3,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,338 · Food and Beverage: $370 · Education: $117 · Travel and Lodging: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,337.50 |
| Food and Beverage | $369.94 |
| Education | $117.37 |
| Travel and Lodging | $104.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $3,442.24 | 2025 | |
| Abbvie INC. | $154.23 | 2022-2023 | Teflaro, Dalvance, Avycaz |
| Gilead Sciences, INC. | $120.17 | 2019 | |
| Mylan Specialty L.P. | $106.75 | 2023 | Tobi Podhaler |
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.46 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $64.08 | 2023 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Alcresta Therapeutics, INC. | $15.24 | 2024 | Relizorb |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.